However, TBK1/IKKε inhibition by Compound II was shown to ameliorate autoimmune disease phenotypes in the Trex1-/- mouse model for Aicardi–Goutières syndrome, decreasing IFN gene signature and autoantibody titres as well as increasing survival.29 The gene discussed is TREX1; the disease is Aicardi-Goutières syndrome.